Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
4(21%)
Results Posted
100%(1 trials)
Terminated
3(16%)

Phase Distribution

Ph phase_1
1
5%
Ph not_applicable
11
58%
Ph phase_3
1
5%
Ph phase_2
2
11%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
1(6.7%)
N/ANon-phased studies
11(73.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

20.0%

1 of 5 finished

Non-Completion Rate

80.0%

4 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(8)
Completed(1)
Terminated(4)
Other(6)

Detailed Status

unknown6
Recruiting4
Terminated3
Not yet recruiting3
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
25.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (6.7%)
Phase 22 (13.3%)
Phase 31 (6.7%)
N/A11 (73.3%)

Trials by Status

terminated316%
unknown632%
not_yet_recruiting316%
withdrawn15%
completed15%
enrolling_by_invitation15%
recruiting421%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04937283Not Applicable

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Recruiting
NCT00499330Phase 3

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Completed
NCT07256457Not Applicable

Postoperative Pulmonary Function Assessment Based on Deep Learning Study

Not Yet Recruiting
NCT03237377Phase 2

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Terminated
NCT07166003

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

Recruiting
NCT06483698

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

Recruiting
NCT06646770Not Applicable

SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)

Not Yet Recruiting
NCT06028412Not Applicable

Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study

Enrolling By Invitation
NCT04931420Phase 2

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

Withdrawn
NCT05477251Not Applicable

Comparative Study on the Efficacy and Safety of Microwave Ablation and Lobectomy in the Treatment of Ground Glass Nodules Located in the Pulmonary Hilar Region

Not Yet Recruiting
NCT04944563Not Applicable

Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field

Recruiting
NCT04969523Not Applicable

Effect of Es-ketamine on Postoperative Delirium Among Old Patients With Lobectomy

Unknown
NCT04904159

Scoring System for Thyroid Gland Pathologies

Unknown
NCT03185754Not Applicable

Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer

Unknown
NCT02888925Not Applicable

Anterior Temporal Epilepsy Neuropsychological Assessment of Faces

Unknown
NCT03108560Not Applicable

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

Unknown
NCT02951897Not Applicable

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

Unknown
NCT00912366

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

Terminated
NCT01373463Phase 1

Cisplatin and Pemetrexed With Radiation Followed by Lobectomy

Terminated

All 19 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
19